Carboxyamidotriazole and Paclitaxel in Treating Patients With Advanced Solid Tumors or Refractory Lymphomas

DISEASE CHARACTERISTICS: * Histologically diagnosed solid tumor (i.e., breast and ovarian epithelial carcinomas) or lymphoma * Slides reviewed at the NCI Laboratory of Pathology * Failure on therapy of proven efficacy for the disease * Prior therapy not required for the following metastatic diseases: * Melanoma * Non-small cell lung cancer * Renal cell carcinoma * No brain metastases * Primary brain tumors (such as glioblastoma multiforme) with stable neurologic deficits allowed * Measurable or evaluable disease required * Demonstrated by physical exam or on radiograph within 2 weeks prior to initiation of treatment OR * Elevated PSA associated with prostate cancer * Other marker-only disease ineligible PATIENT CHARACTERISTICS: Age: * Over 18 Performance status: * ECOG 0-2 Life expectancy: * At least 3 months Hematopoietic: * WBC at least 3,000/mm\^3 * Platelet count at least 100,000/mm\^3 * Hematocrit at least 27% Hepatic: * Liver function tests no greater than 2 times upper limit of normal * Bilirubin normal * PT or PTT no greater than 1.25 times upper limit of normal * Clotting parameters normal * No concurrent anticoagulants other than 1 mg of warfarin per day for prophylaxis Renal: * Creatinine no greater than 1.5 mg/dL OR * Creatinine clearance at least 45 mL/min * No kidney obstruction Cardiovascular: * No cardiac conduction defect requiring antiarrhythmics * No evidence of myocardial infarction or other myocardial damage…